News Results
There are 555,273 News Results
Aug 13, 2017
NEWTON, Mass., Aug. 14, 2017 /PRNewswire/ -- Dynasil Corporation of America (NASDAQ: DYSL), a developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for...
Aug 17, 2017
United Rentals, Inc. (NYSE: URI) (“United Rentals” or “the company”) and Neff Corporation, operating as Neff Rental (“Neff”), today announced that they have entered into a definitive agreement under which...
Aug 16, 2017
LOS ANGELES, Aug. 17, 2017 /PRNewswire/ -- Fashion event agency, A-List Communications, announced its New York Spring/Summer 2018 Women's fashion week schedule for September 11 - 13, which includes a...
Aug 18, 2017
Ensco plc (NYSE: ESV) (“Ensco”) and Atwood Oceanics, Inc. (NYSE: ATW) (“Atwood”) announced today the filing of definitive proxy materials with the U.S. Securities and Exchange Commission (“SEC”) in connection...
Aug 20, 2017
TEL AVIV, Israel, Aug. 21, 2017 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP, TASE: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided...
Aug 27, 2017
LAS VEGAS, Aug. 28, 2017 /PRNewswire/ -- VMworld 2017 --
Aug 31, 2017
PLANO, Texas, Sept. 1, 2017 /PRNewswire/ -- Toyota Motor North America (TMNA) Inc., today reported August 2017 sales of 227,625 units. With one more selling day in August 2017 compared...
Aug 31, 2017
RICHMOND, Va., Sept. 1, 2017 /PRNewswire/ -- Kaléo, a privately-held pharmaceutical company, today announced a donation of 20,000 AUVI-Q(®) (epinephrine injection, USP) Auto-injectors and 5,000 EVZIO(®) (naloxone HCl injection) Auto-injectors...
Sep 7, 2017
BOULDER, Colo., Sept. 8, 2017 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today announced safety results and initial clinical activity from the safety lead-in of the Phase 3...
Sep 8, 2017
BOULDER, Colo., Sept. 9, 2017 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today announced results from Part 2 of the Phase 3 COLUMBUS study evaluating binimetinib, a MEK...
